About Us
Key Management & Scientific
Scientific Advisory Board
Andre Rosowsky, PhD
Dr. Rosowsky received his PhD degree in chemistry from the University of Rochester in 1962. After postodoctoral research in the Department of Chemistry at Harvard University under the direction of Dr. E.J. Corey, he joined the Dana Farber Cancer Institute. Dr. Rosowsky is Associate Professor of Biological Chemistry and Pharmacology at Harvard Medical School. In 1987 he was appointed Associate Professor in the Division of Cancer Pharmacology, now part of the Department of Medical Oncology. He heads a group whose primary goal is the design of novel antifolates as anticancer and antiparasitic drugs.
Krishna Agrawal, PhD
Dr. Agrawal received his PhD degree in pharmacology from the University of Florida. Presently, he is a Regents Professor and Chairman at Tulane University School of Medicine in New Orleans. Research interests that are actively being pursued by Dr. Agrawal in the Department of Pharmacology include mechanisms of drug-induced toxicities; biomarkers; protection of normal tissues from genotoxic agents; growth control; and inhibition of HIV replication.
Dr. Krupa S Rajur MD
Advisory Board Chair, Oncology Research
Dr. Rajur received her MD degree in internal medicine from Tufts University school of medicines and completed fellowship in Nephrology from Brown University RI. Currently she is serving as a nephrologist at Southern New Hampshire Medical Center in Nashua and Dartmouth Hitchcock medical center, Manchester NH.
 
Company Profile
CreaGen Biosciences, Inc. is located in Woburn, MA, on the near north side of the Greater Boston Area. Boston is one of the primary hubs in the world for life sciences research.
(Corporate Fact Sheet)
 more...
News
  2009
Recent Developments
1) Press Release (PDF)
2)
Patent publication

Dr. Rajur chaired the medicinal chemistry symposium of the Northeastern section of American Chemical Society, Marriott Hotel, Burlington, MA, on September 10th, 2009. Symposium title "Recent Developments in Neurodegenerative diseases”

The Boston Society and NESACS applied pharmaceutical sciences and medicinal chemistry symposium titled"Frontiers in Strategies and Technologies to enrich pharmaceutical pipelines” held on
May 21-22, 2009 at the Merck Research Laboratories Boston Amphitheater, Boston, MA. was Hosted and co-sponsored in part by CreaGen Biosciences, Inc.

3rd Annual Advances In Chemical Sciences Symposium held on April 10, 2009 at the Royal Sonesta Hotel in Cambridge, MA. was Hosted and co-sponsored in part by CreaGen Biosciences, Inc.

  more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright 2009 CreaGen Biosciences Inc. All rights reserved.